A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Primary Objectives: • To assess the safety and tolerability of single ascending oral doses of ABP‐671 in Healthy Volunteers (HVs). Secondary Objectives: • To characterize the pharmacokinetics (PK) and pharmacodynamics (PD) profiles of single ascending oral doses of ABP‐671 in HVs.
Epistemonikos ID: a6060767aa884b858a1bc7b0344620ca145e7e29
First added on: May 22, 2024